Cargando…

Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents

PURPOSE: Acanthosis nigricans (AN) is a hyperpigmented dermatosis associated with obesity and insulin resistance (IR). There is no consensus whether AN extension scoring offers added value to the clinical estimation of IR. In this study we aimed to assess and score AN using both a short and an exten...

Descripción completa

Detalles Bibliográficos
Autores principales: Videira-Silva, Antonio, Albuquerque, Carolina, Fonseca, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Pediatric Endocrinology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603613/
https://www.ncbi.nlm.nih.gov/pubmed/31261473
http://dx.doi.org/10.6065/apem.2019.24.2.99
_version_ 1783431545607946240
author Videira-Silva, Antonio
Albuquerque, Carolina
Fonseca, Helena
author_facet Videira-Silva, Antonio
Albuquerque, Carolina
Fonseca, Helena
author_sort Videira-Silva, Antonio
collection PubMed
description PURPOSE: Acanthosis nigricans (AN) is a hyperpigmented dermatosis associated with obesity and insulin resistance (IR). There is no consensus whether AN extension scoring offers added value to the clinical estimation of IR. In this study we aimed to assess and score AN using both a short and an extended version of the scale proposed by Burke et al. and analyze the relationships of both versions with hyperinsulinemia and IR. METHODS: We analyzed data from 139 overweight adolescents (body mass index ≥85th percentile) aged 12–18 with (n=67) or without (n=72) AN who were followed at a pediatric obesity clinic. RESULTS: Adolescents with AN had higher levels of insulin (d=0.56, P=0.003) and HOMA-IR (d=0.55, P=0.003) compared to those without. Neither the short nor the extended versions of AN scores explained either hyperinsulinemia (β=1.10, P=0.316; β=1.15, P=0.251) or IR (β=1.07, P=0.422; β=1.10, P=0.374). The presence of AN alone predicted hyperinsulinemia and the presence of IR in 7.3% (β=2.68, P=0.008) and 7.1% (β=2.59, P=0.009) of adolescents, respectively. CONCLUSIONS: Screening for AN at the neck and axilla is a noninvasive and cost-effective way to identify asymptomatic overweight adolescents with or at risk of developing IR.
format Online
Article
Text
id pubmed-6603613
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society of Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-66036132019-07-10 Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents Videira-Silva, Antonio Albuquerque, Carolina Fonseca, Helena Ann Pediatr Endocrinol Metab Original Article PURPOSE: Acanthosis nigricans (AN) is a hyperpigmented dermatosis associated with obesity and insulin resistance (IR). There is no consensus whether AN extension scoring offers added value to the clinical estimation of IR. In this study we aimed to assess and score AN using both a short and an extended version of the scale proposed by Burke et al. and analyze the relationships of both versions with hyperinsulinemia and IR. METHODS: We analyzed data from 139 overweight adolescents (body mass index ≥85th percentile) aged 12–18 with (n=67) or without (n=72) AN who were followed at a pediatric obesity clinic. RESULTS: Adolescents with AN had higher levels of insulin (d=0.56, P=0.003) and HOMA-IR (d=0.55, P=0.003) compared to those without. Neither the short nor the extended versions of AN scores explained either hyperinsulinemia (β=1.10, P=0.316; β=1.15, P=0.251) or IR (β=1.07, P=0.422; β=1.10, P=0.374). The presence of AN alone predicted hyperinsulinemia and the presence of IR in 7.3% (β=2.68, P=0.008) and 7.1% (β=2.59, P=0.009) of adolescents, respectively. CONCLUSIONS: Screening for AN at the neck and axilla is a noninvasive and cost-effective way to identify asymptomatic overweight adolescents with or at risk of developing IR. Korean Society of Pediatric Endocrinology 2019-06 2019-06-30 /pmc/articles/PMC6603613/ /pubmed/31261473 http://dx.doi.org/10.6065/apem.2019.24.2.99 Text en © 2019 Annals of Pediatric Endocrinology & Metabolism This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Videira-Silva, Antonio
Albuquerque, Carolina
Fonseca, Helena
Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents
title Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents
title_full Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents
title_fullStr Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents
title_full_unstemmed Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents
title_short Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents
title_sort acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603613/
https://www.ncbi.nlm.nih.gov/pubmed/31261473
http://dx.doi.org/10.6065/apem.2019.24.2.99
work_keys_str_mv AT videirasilvaantonio acanthosisnigricansasaclinicalmarkerofinsulinresistanceamongoverweightadolescents
AT albuquerquecarolina acanthosisnigricansasaclinicalmarkerofinsulinresistanceamongoverweightadolescents
AT fonsecahelena acanthosisnigricansasaclinicalmarkerofinsulinresistanceamongoverweightadolescents